On behalf of the Society for Korean Obesity and Metabolism Studies (SOMS), it is our distinct honor to invite you to the SOMS International Conference on Obesity & Metabolism (SICOM 2025), which will be held from November 27 (Thursday) to 29 (Saturday), 2025, at the aT Center in Seoul, Republic of Korea. This year’s theme, “The Golden Age of Obesity Care Begins,” captures the transformative advances that are reshaping our field. With the clinical introduction of semaglutide and tirzepatide, along with a robust pipeline of next-generation therapies, obesity treatment is entering an era of unprecedented efficacy. Moving past robust single-agent injectables, the horizon of obesity treatment expands to include oral medications, innovative combination therapies, and advanced muscle-preserving weight loss approaches. The Asia-Pacific region, home to a large and diverse population affected by obesity, faces both unique challenges and immense opportunities. Understanding and implementing culturally tailored approaches is essential for improving outcomes across the region. SICOM 2025 aspires to become the leading platform for researchers throughout the Asia-Pacific to share insights, foster collaboration, and accelerate progress in obesity and metabolic health. Join us in Seoul to be part of this transformative journey! Warm regards, |
|
![]() Kyoung-Kon Kim Chair, Organizing Committee of SICOM 2025 |
![]() Jee-Hyun Kang President, Society for Korean Obesity and Metabolism Studies (SOMS) |